Luciana Ribeiro, M.D., Ph.D.

Education & Training

• MD, Federal School of Medical Sciences Foundation of Porto Alegre, Brazil, 1995
• Adult Psychiatry Residency (Brazil), Clinics Hospital of Porto Alegre, HCPA, 1999-1996
• PhD, Federal University of Rio Grande do Sul, UFRGS, Brazil. Doctoral degree in Medicine: Medical Clinics, 2000-2004
• M.Sc. Federal University of Rio Grande do Sul, UFRGS, Brazil. Masters degree in Medicine: Medical Clinics, 1998-1999
• Post Doctoral Fellow. Diana Princess of Wales Memorial Foundation Fellow, University of California, Los Angeles (UCLA). Field: Pharmacogenomics, 2005-2006
• Post Doctoral Associate. Department of Psychiatry and Behavioral Sciences University of Miami, Miller School of Medicine, Florida (UM). Field: Translational Research, 2006-2007
• Adult Psychiatry Residency, University of Chicago, 2009

Research Interests

• Pharmacogenetics
• Neuroscience
• Translational Research

Teaching

• Genetic Analysis of the Human Genome Variation in Depression. At the Bioinformatics Department from the Federal University from Rio Grande do Sul, Porto Alegre, Brazil. November 16th 2006.
• Genetic Analysis of the Human Genome Variation in Depression. At the Intensive Care Psychiatric Unit in Petropolis Hospital, Porto Alegre, Brazil. November 20th 2006.
• Genetic Analysis of the Human Genome Variation in Depression. At the I Mood Disorders Symposium at Mae de Deus Hospital, Porto Alegre, Brazil. November 24th 2006.
• [Short Historical of Psychopharmacology and Main Mental Disorders] “Breve Histórico da Psicofarmacologia e Principais Transtornos Mentais”. At the Curso de Extensão: Psicofármacos na Prática Clínica (UNISC), from October 06th to December 15th, 1998.

Selected Publications

• Ribeiro L, Busnello JV, Cantor RM, Whelan F, Whittaker P, Deloukas P, Wong ML, Licinio J. The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport. 2007 Aug; 18(12): 1291-1293. Cited in PubMed; PMID: 17632285.
• Ribeiro L, Andreazza AC, Salvador M, da Silveira TR, Vieira S, Nora DB, Bosa C, Di Napoli F, Schaf DV, Souza DO, Portela LVC, Kapczinski F. Oxidative stress and S100B protein in cirrhotic children. Neurochemical Research. 2007 Sep; 32(9): 1600-1603. Cited in PubMed; PMID: 17514420
• Sharna A, Busnello JV, Ribeiro L, Thakur S, Whelan F, Wong ML, Licinio J. Suicidality Scores During Double-blind Fluoxetine and Desipramine Treatment in Mexican Americans. Journal of Clinical Psychopharmacology. 2007 Feb; 27(1): 99-101. Cited in PubMed; PMID: 17224728
• Portela LV, Tort AB, Schaf DV, Ribeiro L, Nora DB, Walz R, Rotta LN, Silva CT, Busnello JV, Kapczinski F, Gonçalves CA, Souza DO. The serum S100B concentration is age dependent. Acta Scientiae. 2002 Jun; 48(6): 950-952. Cited in PubMed; PMID: 12029017.
• Ribeiro L, Busnello JV, SantAnna MK, Madruga M, Busnello EAD, Kapczinski F. Mirtazapine versus Fluoxetine in the Treatment of Panic Disorder. Brazilian Journal of Medical and Biological Research. 2001 Oct; 34(10): 1303-1307. Cited in PubMed; PMID: 11593305
• Busnello JV, Perizzolo J, Ribeiro L, Kapczinski F. [Fragile X syndrome - clinical, genetic and therapeutical aspects] Síndrome do X frágil - aspectos clínicos, genéticos e terapêuticos. Revista de Medicina da ATM. 2000 Jun; 20(1): 251-255.
• Mabilde LC, Kapczinski F, Ribeiro L, Tocchetto A. [Considerations regarding the pharmacological and psychodynamic treatments for anxiety disorders] Considerações sobre o Tratamento Farmacológico e Psicodinâmico dos Transtornos de Ansiedade. Revista de Psiquiatria do Rio Grande do Sul. 1999 Jan; 21(1): 41-51.
• Ribeiro L, Kapczinski F, Busnello EAD. [Mirtazapine utilization for the treatment of panic disorder] Uso da Mirtazapina no Tratamento do Transtorno do Pânico. Revista de Psiquiatria Clínica. 1998 Apr; 25(4): 194-195.
• Ribeiro L, Souza CAC. [Delusions: conceptualization, classification, differential diagnosis and treatment] Delírios: conceituação, classificação, diagnóstico diferencial e terapêutica. Revista AMRIGS. 1995 Oct; 39(4): 277-283.